Abstract

This paper addresses the etiology, epidemiology, clinical manifestations, diagnostics and treatment for larva migrans. Larva migrans occurs most commonly in tropical areas, in particular, in the Caribbean countries, Africa, South America, and Southeast Asia. Published data demonstrate the increasing number of the imported larva migrans cases in Russia. However, no clear diagnostic benchmarks are still developed. Larva migrans is accounted for by the cutaneous and/or visceral migration of the larvae of the helminths of cats and dogs which are unusual for humans and never develop in adults capable of reproduction. Clinically, the primary lesion is a 2–3-mm width erythematous serpiginous eruption filled with serous fluid. The number of eruptions complies with the number of larvae. Anti-helminthic drugs, i.e., mebendazole, thiabendazole, and albendazole, are recommended for larva migrans. The paper describes multiple cutaneous eruptions caused by larva migrans in a woman living in the northern region of the country. The authors highlight that the diagnosis was challenging. The early diagnosis and prompt treatment for helminthiases associated with cutaneous eruptions prevent gastrointestinal and other dangerous complications. KEYWORDS: larva migrans, migrating worm, cutaneous larva migrans, ancylostomiasis, helminths, mebendazole. FOR CITATION: Efanova E.N., Katanakhova L.L., Samoylova O.I. et al. Multiple cutaneous eruptions in larva migrans: case study. Russian Medical Inquiry. 2020;4(10):647–651. DOI: 10.32364/2587-6821-2020-4-10-647-651.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call